Valuation: Cogstate Limited

Market Cap 647M 440M 398M 368M 333M 628M 41.4B 4.41B 1.75B 22.13B 1.65B 1.62B 70.45B P/E 2027 *
29.8x
P/E 2028 * 23.1x
Enterprise Value 582M 396M 358M 331M 299M 565M 37.25B 3.97B 1.58B 19.91B 1.49B 1.46B 63.39B EV / Sales 2027 *
5.35x
EV / Sales 2028 * 4.51x
Free-Float
56.72%
Yield 2027 *
1.33%
Yield 2028 * 1.62%
1 day-3.19%
1 week+10.64%
Current month+5.51%
1 month-3.45%
3 months+32.85%
6 months+46.77%
Current year+61.06%
1 week 3.22
Extreme 3.22
3.84
1 month 3.22
Extreme 3.22
3.84
Current year 2.01
Extreme 2.01
3.98
1 year 1.75
Extreme 1.75
3.98
3 years 0.8
Extreme 0.795
3.98
5 years 0.8
Extreme 0.795
3.98
10 years 0.16
Extreme 0.155
3.98
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
10/30/26 Free

Chief Executive Officer

355,866 0.2061%
10/29/26 Exercice

Chief Executive Officer

-500,000 0.2907%
10/29/26 Sell

Chief Executive Officer

-500,000 0.2907%
Change 5-day change 1-year change 3-year change Capi.($)
-3.19%+10.64%+27.72%+133.33% 440M
+1.10%-2.67%+62.79%+70.47% 68.45B
-0.02%+8.65%+15.30%+92.65% 61.31B
-0.36%+0.09%+20.16%+97.85% 55.73B
-0.96%+7.41%+10.20%+108.91% 47.51B
-1.25%+2.35%+22.74%+38.34% 44.68B
-2.41%-0.73%+167.89%+794.72% 38.14B
+1.21%-2.56%+20.27%+52.81% 35.85B
-1.74%-1.56%+76.74%+53.76% 33.05B
-2.22%+8.56%-39.26%+397.14% 25.9B
Average -0.98%+3.53%+38.45%+184.00% 41B
Weighted average by Cap. -0.52%+2.85%+40.19%+163.41%

Financials

2027 *2028 *
Net sales 109M 74.09M 67M 61.85M 55.98M 106M 6.97B 742M 295M 3.72B 278M 272M 11.85B 125M 85.2M 77.04M 71.12M 64.37M 121M 8.01B 854M 339M 4.28B 320M 313M 13.63B
Net income 21.75M 14.81M 13.4M 12.37M 11.19M 21.12M 1.39B 148M 58.98M 745M 55.6M 54.41M 2.37B 27.77M 18.91M 17.1M 15.79M 14.29M 26.97M 1.78B 189M 75.31M 951M 70.98M 69.47M 3.03B
Net Debt -64.78M -44.11M -39.89M -36.82M -33.33M -62.89M -4.15B -442M -176M -2.22B -166M -162M -7.06B -82.32M -56.06M -50.69M -46.79M -42.35M -79.92M -5.27B -562M -223M -2.82B -210M -206M -8.97B
Projected Income Statement - Annual - Cogstate Limited
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-11-13 A$3.640 -3.19% 95,170
26-11-12 A$3.760 +3.30% 171,621
26-11-11 A$3.640 +1.11% 683,685
26-11-10 A$3.600 +7.14% 1,104,693
26-11-09 A$3.360 +2.13% 220,119
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Cogstate Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.760AUD
Average target price
4.497AUD
Spread / Average Target
+19.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cogstate Limited